References
- Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485–9.
- Xiao H, Lin M. The application of magnetic resonance imaging in neuromyelitis optica. Chin J Med Imaging 2010;18(1):63–7.
- Smith CH, Miller NR, Newman NJ, Biousse V, et al. Walsh and Hoyt's clinical neuro-ophthalmology[M]. 6th ed. Baltimore, MD: Lippincott Williams & Wilkins, 2005. pp. 293–326.
- Long Y, Qiu W, Lu Z, et al. Aquaporin 4 antibodies in the cerebrospinal fluid are helpful in diagnosing Chinese patients with neuromyelitis optica. Neuroimmunomodulation 2012;19(2):96–102.
- Wingerchuk DM, Hogancamp WF, Obrien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999;53:1107–18.
- Ghezzi A, Bergamaschi R, Martinelli V, et al. Clinical characteristics, course and prognosis of relapsing Devic's neuromyelitis optica. J Neurol 2004;251(1):47–52.
- Yonezu T, Ito S, Mori M, et al. ‘Bright spotty lesions’ on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis. Mult Scler 2013;20:331–7.
- Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485–9.
- Murchison AG, Kitley J, George J, et al. Spinal cord MRI features in neuromyelitis optica (NMO): characteristics and relationship with severity and recovery in longitudinally extensive transverse myelitis (LETM) attacks. Mult Scler 2013;19(11):329.
- Kiyat-Atamer A, Ekizoglu E, Tuzun E, et al. Long-term MRI findings in neuromyeliti optica: seropositive versus seronegativepatients. Eur J Neurol 2013;20:781–7.
- Tackley G, Kuker W, Palace J. Magnetic resonance imaging in neuromyelitis optica. J Mult Scler 2014 20:1153–64.
- Nakamura M, Miyazawa I, Fujihara K, et al. Preferential spinal central gray malter involvement in neuromyelitis optica: an MRI study. J Neurol 2008;252(2):163–70.
- Chu S, Li Z. Diagnosis of neuromyelitis optica with MRI. Mod Chin J Neurol Disord 2012;2:140–2.
- Cabrera-Gomez JA, Quevedo-Sotolongo L, Gonzalez-Quevedo A, et al. Brain magnetic resonance imaging findings in relapsing neuromyelitis optica. Mult Scler 2007;13:186–92.
- Kim JE, Kim SM, Ahn SW, et al. Brain abnormalities in neuromyelitis optica. J Neurol Sci 2011;302(1–2):43–8.
- Li Y, Xie P, Lv F, et al. Brain magnetic resonance imaging abnormalities in neuromyelitis optica. Acta Neurol Scand 2008;118(4):218–25.
- Lu Z, Lv K, Hu X. The cranial magnetic resonance imaging characteristics of patients with neuromyelitis optica. J Neurol 2009;42:370–74.
- Chan KH, Tse CT, Chung CP, et al. Brain involvement in neuromyelitis optica spectrum disorders. Arch Neurol 2011;68:1432–9.
- Pittock SJ, Lennon VA, Krecke K, et al. Brain abnormalities in neuromyelitis optica. Arch Neurol 2006;63:390–6.
- Matthews L, Marasco R, Jenkinson M, et al. Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution. Neurology 2013;80:1330–7.
- Ito S, Mori M, Makino T, et al. “Cloud-like enhancement” is a magnetic resonance imaging abnormality specific to neuromyelitis optica. Ann Neurol 2009;66(3):425–8.
- Long Y, Chen M, Zhang B, et al. Brain gadolinium enhancement along the ventricular and leptomeningeal regions in patients with aquaporin-4 antibodies in cerebral spinal fluid. J Neuroimmunol 2014;269(1–2):62–7.
- Wayne Moore GR. MRI clinical correlations: more than inflammationalone what can MRI contribute to improve the understanding opathological processesin MS. Neurol Sci 2003;206(2):175–9.
- Watanabe RN, Misu T, Miyazawa I, et al. Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis. Mult Scler 2007;13:968–74.